Race is associated with discontinuation of active surveillance of low-risk prostate cancer: Results from the Duke Prostate Center

被引：0
|
作者：
M R Abern
M R Bassett
M Tsivian
L L Bañez
T J Polascik
M N Ferrandino
C N Robertson
S J Freedland
J W Moul
机构：
[1] Duke Cancer Institute,Division of Urology, Department of Surgery and the Duke Prostate Center
[2] Duke University Medical Center,undefined
来源：
Prostate Cancer and Prostatic Diseases | 2013年 / 16卷
关键词：
prostate adenocarcinoma; active surveillance; race;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：85 / 90
页数：5
相关论文
共 50 条
  • [41] Early Experience With Active Surveillance in Low-Risk Prostate Cancer Treated
    Ha, Ji Yong
    Kim, Byung Hoon
    Park, Choal Hee
    Kim, Chun Il
    KOREAN JOURNAL OF UROLOGY, 2014, 55 (03) : 167 - 171
  • [42] USE OF HOLEP IN MEN ON ACTIVE SURVEILLANCE FOR LOW-RISK PROSTATE CANCER
    Schober, Jared
    Stensland, Kristian
    Mandeville, Jessica
    Moinzadeh, Alireza
    Canes, David
    JOURNAL OF UROLOGY, 2020, 203 : E1188 - E1188
  • [43] Active surveillance for low-risk prostate cancer: Practice across Europe
    Azmi, Aini
    Dillon, Ruth
    Marignol, Laure
    Borghesi, Simona
    Dunne, Mary
    Power, Richard
    O'Neill, Brian
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (05)
  • [44] Super active surveillance for low-risk prostate cancer | Opinion: Yes
    Reis, Leonardo O.
    Andrade, Danilo L.
    Bianco, Fernando J., Jr.
    INTERNATIONAL BRAZ J UROL, 2019, 45 (02): : 210 - 214
  • [45] Multidisciplinary Care and Pursuit of Active Surveillance in Low-Risk Prostate Cancer
    Aizer, Ayal A.
    Paly, Jonathan J.
    Zietman, Anthony L.
    Nguyen, Paul L.
    Beard, Clair J.
    Rao, Sandhya K.
    Kaplan, Irving D.
    Niemierko, Andrzej
    Hirsch, Michelle S.
    Wu, Chin-Lee
    Olumi, Aria F.
    Michaelson, M. Dror
    D'Amico, Anthony V.
    Efstathiou, Jason A.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (25) : 3071 - 3076
  • [46] Enzalutamide versus active Surveillance in Patients with Low-risk Prostate Cancer
    Dunst, Juergen
    Krug, David
    STRAHLENTHERAPIE UND ONKOLOGIE, 2023, 199 (02) : 201 - 203
  • [47] Low-Risk Prostate Cancer Patients on Active Surveillance: Utility of Immunohistochemistry
    Poveda, J.
    Eldefrawy, A.
    Umar, S.
    Soloway, M.
    Jorda, M.
    MODERN PATHOLOGY, 2013, 26 : 241A - 241A
  • [48] Active surveillance for low-risk prostate cancer - in pursuit of a standardized protocol
    Sosnowski, Roman
    Kamecki, Hubert
    Daneshmand, Siamak
    Rudzinski, Jan K.
    Bjurlin, Marc A.
    Giganti, Francesco
    Roobol, Monique J.
    Klotz, Laurence
    CENTRAL EUROPEAN JOURNAL OF UROLOGY, 2020, 73 (02) : 123 - 126
  • [49] Active Surveillance for Low-Risk Prostate Cancer Worldwide: The PRIAS Study
    Bul, Meelan
    Zhu, Xiaoye
    Valdagni, Riccardo
    Pickles, Tom
    Kakehi, Yoshiyuki
    Rannikko, Antti
    Bjartell, Anders
    van der Schoot, Deric K.
    Cornel, Erik B.
    Conti, Giario N.
    Boeve, Egbert R.
    Staerman, Frederic
    Vis-Maters, Jenneke J.
    Vergunst, Henk
    Jaspars, Joris J.
    Stroelin, Petra
    van Muilekom, Erik
    Schroder, Fritz H.
    Bangma, Chris H.
    Roobol, Monique J.
    EUROPEAN UROLOGY, 2013, 63 (04) : 597 - 603
  • [50] Active Surveillance: Very Much "Preferred" for Low-Risk Prostate Cancer
    Cooperberg, Matthew R.
    Lin, Daniel W.
    Morgan, Todd M.
    Chapin, Brian F.
    Chen, Ronald C.
    Eggener, Scott E.
    JOURNAL OF UROLOGY, 2022, 207 (02): : 262 - 264
12345